Rutosides for prevention of post-thrombotic syndrome

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 9, 2015, Pages

  Morling, Joanne R ^a   Yeoh, Su Ern ^b   Kolbach, Dinanda N ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RUTOSIDE DERIVATIVE; PLANT EXTRACT; RUTOSIDE;

ADOLESCENT; ADULT; AGED; CONTROLLED CLINICAL TRIAL (TOPIC); DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; THROMBOSIS PREVENTION; AESCULUS; CHEMISTRY; COMPLICATION; PHYTOTHERAPY; POSTTHROMBOTIC SYNDROME; PROCEDURES; VEIN THROMBOSIS;

AESCULUS; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; POSTTHROMBOTIC SYNDROME; RUTIN; VENOUS THROMBOSIS;

EID: 84964694017     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005626.pub3     Document Type: Review

References (21)

1. Monreal M, Callejas JM, Martorell A, Sahuquillo JC, Contel E. Prevention of post-thrombotic syndrome with hidrosmina: a prospective pilot study. Phlebology 1997;12(1):21-4.
2. Bombardelli E, Morazzoni P, Griffini A. Aesculus hippocastanum L. Fitoterapia 1996;67(6):483-511.
3. Cesarone MR, Belcaro G, Pellegrini L, Ledda A, Vinciguerra G, Ricci A, et al. HR, 0-(beta-hydroxyethyl)-rutosides; (Venoruton): rapid relief of signs/symptoms in chronic venous insufficiency and microangiopathy: a prospective, controlled study. Angiology 2005;56(2):165-72.
4. Facino RM, Carini M, Stefani R, Aldini G, Saibene L. Anti-elastase and anti-hyaluronidase activities of saponins and sapogenins from Hedera helix, Aesculus hippocastanum, and Ruscus aculeatus: factors contributing to their efficacy in the treatment of venous insufficiency. Archiv der Pharmazie 1995;328(10):720-4.
5. Guillaume M, Padioleau F. Veinotonic effect, vascular protection, antiinflammatory and free radical scavenging properties of horse chestnut extract. Arzneimittelforschung 1994;44(1):25-35.
6. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available form www.cochrane-handbook.org. The Cochrane Collaboration.
7. Iafrati MD, Welch H, O'Donnell TF, Belkin M, Umphrey S, McLaughlin R. Correlation of venous noninvasive tests with the Society of Vascular Surgery/International Society for Cardiovascular Surgery clinical classification of chronic venous insufficiency. Journal of Vascular Surgery 1994;19(6):1001-7.
8. Kolbach DN, Sandbrink MWC, Hamulyak K, Prins MH, Neumann MHAM. Non-pharmaceutical measures for prevention of post-thrombotic syndrome. Cochrane Database of Systematic Reviews 2003, Issue 3. [DOI: 10.1002/14651858.CD004174.pub2]
9. Lorenz D, Marek ML. Das therapeutische wirksame Prinzip der Rosskastanie (Aesculus hippocastanum). Arzneimittelforschung 1960;10:263-72.
10. Meissner MH, Zierler BK, Bergelin RO, Chandler WL, Strandness DE Jr. Coagulation, fibrinolysis, and recanalization after acute deep venous thrombosis. Journal of Vascular Surgery 2002;35(2):278-85.
11. Morling JR, Yeoh SE, Kolbach DN. Rutosides for treatment of post-thrombotic syndrome. Cochrane Database of Systematic Reviews 2015, Issue 9. [DOI: 10.1002/14651858.CD005625.pub3]
12. Moyses C, Cederholm-Williams SA, Michel CC. Haemoconcentration and accumulation of white cells in the feet during venous stasis. International Journal of Microcirculation: Clinical and Experimental 1987;5(4):311-20.
13. Partsch H. Compression therapy of the legs. A review. Journal of Dermatologic Surgery and Oncology 1991;17(10):799-805.
14. Pittler MH, Ernst E. Horse chestnut seed extract for chronic venous insufficiency. Cochrane Database of Systematic Reviews 2012, Issue 11. [DOI: 10.1002/14651858.CD003230.pub4]
15. Prandoni P, Lensing AW, Cogo A, Cuppini S, Villalta S, Carta M, et al. The long-term clinical course of acute deep venous thrombosis. Annals of Internal Medicine 1996;125(1):1-7.
16. Sarin S, Andaz A, Shields DA, Scurr JH, Coleridge Smith PD. Neutrophil activation in venous disease. Journal of Vascular Surgery 1993;17:444.
17. Schrader E, Schwankl W, Sieder C, Christoffel V. Comparison of the bioavailability of beta-aescin after single oral administration of two different drug formulations containing an extract of horse-chestnut seeds [Vergleichende Untersuchung zur Bioverfügbarkeit von ß-Aescin nach oraler Einmalverabreichung zweier Rosskastaniensamenextrakt enthaltender, galenisch unterschiedlicher Darreichungsformen]. Pharmazie 1995;50(9):623-7.
18. Thomas PR, Nash GB, Dormandy JA. White cell accumulation in dependent legs of patients with venous hypertension: a possible mechanism for trophic changes in the skin. BMJ 1988;296(6638):1693-5.
19. Widmer LK, Zemp E, Widmer TM, Schmitt HE, Brandenberg E, Voelin R, et al. Late results in deep vein thrombosis of the lower extremity. Vasa 1985;14(3):264-8.
20. Kolbach DN, Prins MH. Rutosides for prevention of post thrombotic syndrome. Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: 10.1002/14651858.CD005626]
21. Morling JR, Yeoh SE, Kolbach DN. Rutosides for prevention of post-thrombotic syndrome. Cochrane Database of Systematic Reviews 2013, Issue 4. [DOI: 10.1002/14651858.CD005626.pub2]